Read more

April 20, 2021
1 min read
Save

Zimmer Biomet receives 510(k) clearance for robotic partial knee system

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Zimmer Biomet Holdings Inc. announced it has received 510(k) clearance from the FDA for the Rosa Partial Knee System for robotically assisted partial knee replacement.

The newest addition to Rosa Robotics and a component of ZBEdge, the partial knee system features proprietary 2D and 3D X-Atlas (Zimmer Biomet) imaging technology and real-time intraoperative data collection on soft-tissue and bone anatomy to improve bone cut accuracy and range of motion gap analysis, according to a company press release. The release noted intraoperative data collected by the partial knee system can be combined with preoperative and postoperative data collected by the company’s mymobility application and consolidated and analyzed by OrthoIntel (Zimmer Biomet), an orthopedic intelligence platform designed to uncover new clinical insights throughout the episode of care and help surgeons and care teams make informed decisions and optimize care. It is also designed for compatibility with the Persona Partial Knee by Zimmer Biomet.

“The FDA clearance of the Rosa Partial Knee System just 2 years after the introduction of the Rosa Total Knee System builds on the success of our Rosa robotics portfolio, which is designed to help enhance surgical accuracy, precision and efficiency through the use of intraoperative data that can personalize each procedure. As a result, the Rosa Partial Knee System empowers patients to truly get the knee that is the best fit for their needs,” Ivan Tornos, chief operating officer at Zimmer Biomet, said in the release. “The Rosa Partial Knee System is the latest innovative component of ZBEdge, our suite of seamlessly integrated technologies that combines data analytics, robotics and connected devices and services to inform care decisions. We are excited about these bold new technologies and the role that Zimmer Biomet can play in reshaping orthopedic procedures and restoring patients’ quality of life.”